Effects of Drugs Taken During Pregnancy
There are many medications
and drugs that can have serious effects on a fetus' development. During
gestation, almost all drugs cross the placenta and affect the unborn child.
It is clear that women who engage in consumption of many illegal and legal
drugs during pregnancy are at increased risk for complications, including
premature labor and delivery. They are also more likely to lose a fetus
through miscarriages and stillbirths than are women who abstain from drugs.
The greater the extent of the drug- use, the more likely there will be adverse
consequences. The timing of drug use during a pregnancy related to types of
consequences. For example from the fourth to the eighth week following
conception, drug use is more likely to increase the risk of spontaneous
abortions and physical malformations of the newborn than is drug use
later on in pregnancy. Use of drugs after the eighth month of pregnancy
is often associated with retarded growth, prematurity, low birth weight,
and neurological damage.
Pregnant women should take extra precautions to avoid using such
substances. Drugs and medications that should be avoided are discussed
in detail below.
Antibiotics
Long-term use of prescription antibiotics may cause damage to a developing fetus. Nitrofurantoin may cause jaundice. The acne medicine, Accutane, may cause severe birth defects if taken during pregnancy. Tetracycline may cause stained teeth and bone deformities. Gentamycin, kanamycin, neomycin, streptomycin, and vancomycin all may cause deafness. Various fetal abnormalities may result from taking some drugs prescribed for diabetics (Hyde and DeLamater, p.157).
Alcohol
Alcohol consumed by a pregnant woman is absorbed by the placenta and directly affects the fetus (Hyde and DeLamater, p.158). A variety of malformations and disorders occur due to alcohol use during pregnancy. These defects are collectively called Fetal Alcohol Syndrome (FAS). Some characteristics of Fetal Alcohol Syndrome are mental retardation; both prenatal and postnatal growth deficiencies; small eye openings; a small brain; and joint, limb, and heart malformations (Hyde and DeLamater, p.158). Alcohol consumption during pregnancy is detrimental to a fetus' health. Please abstain from drinking any amount of alcohol during pregnancy.
Cocaine
Cocaine use during pregnancy may result in a premature birth (Handler et al., 1991) and low birth weight (Phibbs et al., 1991). The only physical effect that has been regularly associated with cocaine use is a smaller head circumference (Cherukuri et al., 1988). This implies that cocaine-exposed children are more likely to be microcephalic, which is associated with poor growth and low intelligence-test scores. Neurological deficits and central nervous system abnormalities have been reported in infants exposed to cocaine in utero (O'Shea, 1995). It is also reported that children are more irritable at 3 to 6 months of age. At 18 months, they have difficulty focusing their attention; more behavioral problems are evident in such children (Vogel, 1997).
Steroids
Synthetic hormones such as progestin can cause a female fetus to be masculinized (Hyde and DeLamater, 158). Some, but not all studies show that corticosteroids are linked with low birth weight, stillbirth, and cleft palate (Ostensen, 1994). Large amounts of vitamin A are associated with cleft palate. Eccessive amounts of vitamin D, B6, and K have been linked with fetal defects. Diethylstilbestrol (DES), a potent estrogen, has been shown to "cause cancer in the vagina in girls whose mothers took the drug while pregnant" (Herbst, 1972). An increased risk of low birth weight is associated with long-term exposure to DES (Zhang and Bracken, 1995).
Other Drugs
The U.S. Public Health Service claims that maternal cigarette smoking
causes low birth weight, increased incidence of premature birth,
and retarded fetal growth. Some antihistamines may cause malformations
in a fetus. Even common medications like aspirin may cause blood
problems in a developing fetus (Cunningham et al., 1989).
The psychoactive chemical in marijuana is able to cross the placental
barrier (Harbison and Mantilla-Plata, 1972; Idanpaan-Heikkila et
al., 1969). Some evidence shows that marijuana inhibits ovulation
(Abel, 1984); thus using marijuana may make conception more difficult.
A Canadian study compared pregnant women who used marijuana with
pregnant nonusers. According to the study, there were no differences
between the two groups in terms of miscarriage, complications during
birth, or incidence of birth defects. However, the infants of the
marijuana users had more tremors and more visual problems during
their preschool years (Fried, 1986). Lower scores on intelligence
tests and poor task performance have also been reported in six-year-olds
who had been exposed to marijuana in utero (Day and Richardson,
1994).
Although x-rays are not considered a drug, they can damage the fetus.
Risk of damage is particularly high during the first 42 days after
conception (Hyde and DeLamater, p.159).
Dads and Drugs
Little research has been done on the effects of a man's drug use on a fetus. However, drugs taken by men before conception may cause birth defects because some drugs can damage the sperm and their genetic contents (Narod et al., 1988). Studies have shown that an increase risk of childhood cancer occurs when a father smokes cigarettes even when the mother does not (John et al., 1991). Hopefully future research will clarify any other effects of a father's use of drugs on his children.
References
Abel, Ernest L. (1984). Fetal Alcohol Syndrome and Fetal Alcohol
Effects. New York: Plenum
Cherukuri, R., Minkoff, H. Feldman, J., Parekh, A., and Glass, L.
(1988). A cohort study of alkaloidal cocaine ("crack")
in pregnancy. Obstetrics and Gynecology, 72, 147-151.
Cunningham, F. Gary, MacDonald, Paul C., and Grant, Norman F. (1989).
Williams Obstetrics (18th ed.). Norwalk, CT: Appleton and Lange.
Day, Nancy L., and Richardson, Gale. (1994). Comparative teratogenicity
of alcohol and other drugs. Alcohol Health and Research world, 42-48.
Fried, Peter A. (1986). Marijuana in pregnancy. In I. J. Chasnott
(Ed.), Drug use in Pregnancy: Mother and Child. Boston: MTP Press.
Handler, A., Kistin, N., Davis, J., and Ferre, C. (1991). Cocaine
use During Pregnancy: Perinatal Outcomes. American Journal of Epidemiology,
133, 818-825.
Harbison, R. D., and Mantilla-Plata, B. (1972). Prenatal Toxicity,
Maternal Distribution and Placental Transfer of Terahydrocannabinol.
Journal of Pharmacology and Experimental Therapeutics, 180, 446-453.
Herbst, A. (1972). Clear Cell Adenocarcinoma of the Genital Tract
in Young Females. New England Journal of Medicine, 287(25), 1259-1264.
Hyde, Janet S., DeLamater, John D. (2000). Understanding Human Sexuality,
Seventh Edition, p.157-160
Idanpaan-Heikkila, J., et al. (1969). Placental Transfer of Tritiated-1
Tetrahydocannabinol. New England Journal of Medicine, 281, 330.
John, E. M., Savitz, D. A., and Sandler, D.P. (1991). Prenatal Exposure
to Parents' Smoking and Childhood Cancer. American Journal of Epidemiology,
133, 123-132.
Narod, Steven A., et al. (1988). Human Mutagens: Evidence from Paternal
Exposure? Environmental and Mollecular Mutagenesis, 11, 401-415.
O'Shea, P. A. (1995). Congenital Defects and their Causes. In D.
R. Constan, R. V. Handing, Jr. and D.B. Singer (Eds.), Human Reproduction:
Growth and Development. Boston: Little, Brown.
Ostensen, Monika. (1994). Optimisation of Antiheumatic Drug Treatment
in Pregnancy. Clinical Pharmacokinetics, 27, 486-503.
Phibbs, C. S., Bateman, D. A., and Schwartz, R. M. (1991). The Neonatal
Costs of Maternal Cocaine Use. Journal of the American Medical Association,
266, 1521-1526.
Vogel, Gretchen. (1997). Cocaine Wreaks Subtle Damage on Developing
Brains. Science, 278, 38-39.
Zhang, Heping, and Bracken, M. B. (1995). Tree-based Risk Factor
Analysis of Preterm Delivery and Small-for-gestational-age Birth.
American Journal of Epidemiology, 141, 70-78.